Propanc Biopharma, Inc. (PPCB)
PPCB Stock Price Chart
Explore Propanc Biopharma, Inc. interactive price chart. Choose custom timeframes to analyze PPCB price movements and trends.
PPCB Company Profile
Discover essential business fundamentals and corporate details for Propanc Biopharma, Inc. (PPCB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
12 Nov 2012
Employees
1.00
Website
https://www.propanc.comCEO
James Nathanielsz
Description
Propanc Biopharma, Inc. (PPCB) is an Australian biopharmaceutical firm dedicated to developing innovative treatments for various cancers, with a particular focus on pancreatic, ovarian, and colorectal malignancies. The company's leading therapeutic candidate, PRP, is a unique formulation currently in the preclinical stage of development. This product is designed to enhance the effectiveness of multiple enzymes that work together to combat cancer. Propanc Biopharma is also engaged in a collaborative research effort with the University of Jaén, initiating the POP1 joint drug discovery program. Founded in 2007, the entity was originally known as Propanc Health Group Corporation before officially changing its name to Propanc Biopharma, Inc. in April 2017. The company's headquarters are located in Camberwell, Australia.
PPCB Financial Timeline
Browse a chronological timeline of Propanc Biopharma, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Stock split effective on 18 May 2026
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 May 2026
EPS came in at -$7.00 .
Earnings released on 17 Feb 2026
EPS came in at -$0.30 .
Earnings released on 14 Nov 2025
EPS came in at -$0.39 .
Earnings released on 29 Sept 2025
EPS came in at -$0.35 .
Earnings released on 15 May 2025
EPS came in at -$12.50 .
Earnings released on 14 Feb 2025
EPS came in at -$32.23 .
Stock split effective on 29 Jan 2025
Shares were split 1 : 60000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2024
EPS came in at -$287.82 .
Earnings released on 30 Sept 2024
EPS came in at -$95.95 .
Earnings released on 15 May 2024
EPS came in at -$625.00 .
Earnings released on 20 Feb 2024
EPS came in at -$1.88k .
Earnings released on 14 Nov 2023
EPS came in at -$2.50k .
Earnings released on 28 Sept 2023
EPS came in at -$0.13 .
Stock split effective on 23 May 2023
Shares were split 1 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2023
EPS came in at -$0.42 .
Earnings released on 9 Feb 2023
EPS came in at -$0.53 .
Earnings released on 14 Nov 2022
EPS came in at -$2.13 .
Earnings released on 28 Sept 2022
EPS came in at -$5.26 .
Earnings released on 16 May 2022
EPS came in at -$625.00k .
Earnings released on 14 Feb 2022
EPS came in at -$1.25m .
Earnings released on 12 Nov 2021
EPS came in at -$1.25m .
Earnings released on 28 Sept 2021
EPS came in at -$83.30 .
PPCB Stock Performance
Access detailed PPCB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
